ALKERMES | ALKS - Interessi Passivi Sul Debito

Prezzo Delle Azioni
33.59
Cambio Giornaliero
-0.13 -0.37%
Mensile
-3.60%
Annuale
5.68%
Q2 Previsione
32.32




Interessi Passivi Sul Debito Cambiamento Data
AbbVie USD 645M 69M 2026-03
Acadia Pharmaceuticals USD 0 4.12M 2024-09
ALKERMES USD 12.28M 7.63M 2025-12
Amgen USD 657M 4M 2026-03
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
Coherus Biosciences USD 2.25M 76K 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 255M 1000K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Ionis Pharmaceuticals USD 17M 1000K 2026-03
J&J USD 43M 25M 2026-03
Merck USD 479M 67M 2026-03
Minerva Neurosciences USD 2.31M 60K 2024-06
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Otsuka Holdings JPY 2.21B 866M 2025-12
Ovoca Bio EUR 7K 6K 2022-06
Pfizer USD 711M 59M 2025-12
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Vertex Pharmaceuticals USD 3.3M 0 2025-12